Advanced Research on Spine Tumor
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 31 March 2025 | Viewed by 50
Special Issue Editor
Interests: spine; spine tumor surgery; metastatic spine tumor; low back pain; ossified spinal ligament
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Despite advances in the treatment of primary and metastatic tumors, clinical outcomes are still unfavorable. The majority of primary tumors have a poor response rate to chemotherapy and conventional radiotherapy, and lack the feasibility of oncologically appropriate surgical resection. The skeleton is the third most common site of metastases after the lungs and liver, with the spine being the most frequently affected bone. Metastatic spinal tumors often result in severe pain and neurological symptoms, reducing the performance status (PS). In metastatic tumor patients, a decrease in PS not only directly affects mortality, but also affect it indirectly by preventing the application of effective systemic therapies. Clinicians have a number of issues that need to be resolved and improved in the management and treatment of spinal tumors.
This Special Issue of Cancers aims to highlight recent advanced research on spine tumor which can improve the understanding of different assessments and/or innovative and personalized treatments for the management of primary and metastatic spinal tumors. Authors are encouraged to submit their original research, including systematic reviews and meta-analyses, clinical trials, observational studies, case series study and experimental work which presents recent advances in the management and treatment of spinal tumors.
Dr. Satoshi Kato
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- diagnosis
- treatment strategy
- prognostic factors and scoring systems
- pain management
- surgical techniques
- spondylectomy/vertebrectomy
- stereotactic body radiotherapy
- particle beam radiation therapy
- minimum invasive treatment
